Frequently Asked Questions

Q: What is the collaboration between the University of North Carolina at Chapel Hill (UNC–Chapel Hill) and Deerfield Management?

A: UNC-Chapel Hill is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate the translation of research in UNC-Chapel Hill faculty laboratories into clinical therapeutics. Pinnacle Hill is a Deerfield company that will support UNC-Chapel Hill's innovative translational research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.

Pinnacle Hill will fund projects with the aim of establishing novel therapeutics to cure life-altering diseases.

Through Pinnacle Hill, Deerfield has committed up to $65 million in initial funding to support promising UNC-Chapel Hill translational research. Deerfield will provide operational support and may make additional capital investments into spin-off companies that emerge from UNC-Chapel Hill projects and show commercial potential.

Q: Who is eligible to apply?

A: Principal Investigators whose full-time employer is UNC-Chapel Hill or who have a faculty appointment at UNC-Chapel Hill and are subject to UNC-Chapel Hill’s policies regarding the conduct of research and ownership of intellectual property.

Q: How can I apply?

A: To submit an application, please visit the Request for Proposal (RFP) page on the Pinnacle Hill website.

Q: How many calls for proposal are there in a year?

A: There are two calls for proposals each year.

Q: Does Pinnacle Hill have a therapeutic area of interest?

A: No – We welcome applications from all therapeutic areas.

Additional FAQs are available once eligible applicants have registered through the submission portal.